Federica Di Vincenzo

23PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Human impacts of climate change and human adaptationRheumatology and arthritisAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 08, 2026
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weighting.

|May 05, 2026
Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium Net.

|Apr 15, 2026
Adverse Childhood Experiences and Disease Activity Are Associated with Post-Traumatic Stress Symptoms in Crohn's Disease.

Giorgia Spagnolo, Daniele Ferrarese, Federica Di Vincenzo

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

|Jul 12, 2025
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review.

Federica Di Vincenzo, Antonio Maria D'Onofrio, Angelo Del Gaudio

|Jun 27, 2025
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study.

Franco Scaldaferri, Antonio Maria D'Onofrio, Elena Chiera

Pageof 4

Frequent Collaborators

14 joint publications

Franco Scaldaferri

8 joint publications

Antonio Gasbarrini

6 joint publications

Pierluigi Puca

5 joint publications

Loris Riccardo Lopetuso